$14.1 Million is the total value of ACACIA RESEARCH CORP's 4 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
NR | NEWPARK RES INC | $6,234,271 | +32.1% | 902,210 | 0.0% | 44.17% | -0.4% | |
CMTL | COMTECH TELECOMMUNICATIONS C | $4,207,245 | -4.3% | 480,828 | 0.0% | 29.81% | -27.8% | |
Buy | ZIMVIE INC | $3,042,055 | +230.8% | 323,279 | +294.7% | 21.55% | +149.4% | |
THR | THERMON GROUP HLDGS INC | $631,810 | +3.3% | 23,000 | 0.0% | 4.48% | -22.1% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
COMTECH TELECOMMUNICATIONS C | 4 | Q3 2023 | 83.4% |
NEWPARK RES INC | 3 | Q3 2023 | 44.3% |
ZIMVIE INC | 3 | Q3 2023 | 21.6% |
THERMON GROUP HLDGS INC | 2 | Q3 2023 | 5.7% |
CIRCOR INTL INC | 1 | Q4 2022 | 16.5% |
ITERIS INC NEW | 1 | Q4 2022 | 0.2% |
View ACACIA RESEARCH CORP's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Spok Holdings, Inc | June 29, 2022 | 966,883 | - |
Theravance Biopharma, Inc.Sold out | June 11, 2020 | 0 | 0.0% |
Evofem Biosciences, Inc. | June 09, 2020 | 1,000 | 0.0% |
Veritone, Inc. | March 10, 2020 | 1,120,432 | 4.4% |
IMMERSION CORP | December 26, 2019 | 1,533,991 | - |
View ACACIA RESEARCH CORP's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
DEF 14A | 2024-04-19 |
8-K | 2024-04-17 |
4 | 2024-03-25 |
4 | 2024-03-25 |
4 | 2024-03-18 |
10-K | 2024-03-15 |
8-K | 2024-03-14 |
8-K | 2024-03-14 |
4 | 2024-03-11 |
4 | 2024-03-11 |
View ACACIA RESEARCH CORP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.